Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning

Area of Science:

• Neuroscience
• Cognitive Science
• Pharmacology

Background:

• N-methyl-d-aspartate (NMDA) receptor activation is theorized to be crucial for learning and memory.
• NMDA receptor antagonists disrupt learning, supporting this hypothesis.
• Investigating glycine site modulators offers insight into NMDA receptor function in memory.

Purpose of the Study:

• To examine the effects of glycine site antagonists and partial agonists on learning and memory consolidation.
• To determine if these compounds can prevent memory deficits induced by hypoxia or pentylenetetrazole (PTZ).
• To explore the role of NMDA receptor activation in memory impairment.

Main Methods:

• Utilized a single-trial inhibitory avoidance learning paradigm in mice.
• Administered hypoxia or PTZ post-training to induce memory consolidation deficits.
• Pretreated mice with glycine site antagonists (7-chlorokynurenic acid) and partial agonists (1-aminocyclopropanecarboxylic acid, (+)HA-966).

Main Results:

• Glycine site antagonists and partial agonists prevented memory deficits caused by hypoxia and PTZ.
• These compounds did not affect scopolamine-induced learning impairments.
• ACPC also prevented deficits induced by glutamate transport inhibition.
• (+)HA-966, 7KYN, and ACPC dose-dependently facilitated both learning acquisition and memory consolidation, effects reversed by glycine.

Conclusions:

• Memory deficits induced by hypoxia and PTZ involve NMDA receptor activation.
• Glycine site antagonists and partial agonists protect against memory deficits by influencing consolidation, not acquisition.
• NMDA receptor modulation at the glycine site presents a potential therapeutic target for memory disorders.